Immediate Impact
2 from Science/Nature 57 standout
Citing Papers
Glycan-specific molecularly imprinted polymers towards cancer diagnostics: merits, applications, and future perspectives
2024 Standout
Colorectal cancer
2024 Standout
Works of Geoffrey Chong being referenced
LBA25 FRESCO-2: A global phase III multiregional clinical trial (MRCT) evaluating the efficacy and safety of fruquintinib in patients with refractory metastatic colorectal cancer
2022
A Phase I Biodistribution and Pharmacokinetic Trial of Humanized Monoclonal Antibody Hu3s193 in Patients with Advanced Epithelial Cancers that Express the Lewis-Y Antigen
2007
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Geoffrey Chong | 294 | 374 | 172 | 56 | 740 | |
| Tatsuya Suzuki | 349 | 323 | 194 | 83 | 853 | |
| H.‐G. Mergenthaler | 204 | 535 | 170 | 33 | 891 | |
| Alessia Bari | 540 | 441 | 172 | 53 | 884 | |
| Igor Aurer | 520 | 437 | 221 | 84 | 924 | |
| Adam M. Petrich | 538 | 380 | 218 | 57 | 879 | |
| Julie Chang | 360 | 366 | 249 | 42 | 776 | |
| M. Jesús Nambo | 529 | 444 | 110 | 42 | 871 | |
| Judith Huerta‐Guzmán | 396 | 396 | 94 | 42 | 655 | |
| D.J. van Spronsen | 358 | 396 | 82 | 35 | 843 | |
| Christopher McNamara | 313 | 217 | 128 | 36 | 705 |
All Works
Login with ORCID to disown or claim papers
Loading papers...